MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
Xu Zhang(Xuzhou Medical College), Xuejiao Liu(Xuzhou Medical College)
Cited by 46
Related Papers
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
|Journal of Hematology & Oncology|2016|80
RETRACTED ARTICLE: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death
|Cell Death and Disease|2021|42
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
|Journal of Cellular and Molecular Medicine|2020|32
GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma
|Cell Death Discovery|2022|22
FoxR2 promotes glioma proliferation by suppression of the p27 pathway
|Oncotarget|2017|12